Novel RNA interference-based therapies for sepsis

Abstract

Introduction: Sepsis is an extremely fast-paced disease, initiated by an infection that can progress to multiple organ dysfunction and death. The complexity associated with sepsis makes the therapies difficult to develop. Moreover, the ‘one-fits-all' kind of therapy is far from being realistic.

Areas covered: This review provides a conspectus of the current results of sepsis therapies and their benefits, focusing on the development of small interfering RNA (siRNA) therapeutics for targeting immune cells and sepsis pathways.

Expert opinion: The question, ‘When will an effective therapy for sepsis be available for patients?' remains unanswered. New RNA interference-mediated therapies are emerging as novel approaches for the treatment of sepsis by downregulating key inflammatory cytokine expression. Strategies that exploit multimodal gene silencing using siRNA and targeted delivery systems are discussed in this review. Some of these strategies have shown positive results in preclinical model of sepsis.

Keywords::

• chemokines
• compensatory anti-inflammatory response syndrome
• cytokines
• delivery
• microRNA
• nanoparticle
• RNA interference
• sepsis
• small interfering RNA
• systemic inflammatory response syndrome

Notes

This box summarizes key points contained in the article.